These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23423249)

  • 1. Predictors of renal relapse in Korean patients with lupus nephritis who achieved remission six months following induction therapy.
    Moon SJ; Park HS; Kwok SK; Ju JH; Choi BS; Park KS; Min JK; Kim HY; Park SH
    Lupus; 2013 Apr; 22(5):527-37. PubMed ID: 23423249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term renal survival of paediatric patients with lupus nephritis.
    Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
    Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
    Hailu GT; Hussen SU; Getachew S; Berha AB
    BMC Nephrol; 2022 Jun; 23(1):214. PubMed ID: 35715762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
    Joo YB; Kang YM; Kim HA; Suh CH; Kim TJ; Park YW; Lee J; Lee JH; Yoo DH; Bae SC; Lee HS; Bang SY
    Int J Rheum Dis; 2018 May; 21(5):1031-1039. PubMed ID: 29611341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis.
    Das U; Patel R; Guditi S; Taduri G
    Lupus; 2021 May; 30(6):876-883. PubMed ID: 33611965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained remission of lupus nephritis.
    Barber CE; Geldenhuys L; Hanly JG
    Lupus; 2006; 15(2):94-101. PubMed ID: 16539280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis.
    Suzuki E; Yashiro-Furuya M; Temmoku J; Fujita Y; Matsuoka N; Hazama M; Asano T; Sato S; Kobayashi H; Watanabe H; Kanno T; Migita K
    Int J Rheum Dis; 2021 Dec; 24(12):1500-1509. PubMed ID: 34636151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
    Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
    Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis.
    Zen M; Fuzzi E; Loredo Martinez M; Depascale R; Fredi M; Gatto M; Larosa M; Saccon F; Iaccarino L; Doria A
    Rheumatology (Oxford); 2022 Feb; 61(2):688-695. PubMed ID: 33909900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy.
    De Rosa M; Azzato F; Toblli JE; De Rosa G; Fuentes F; Nagaraja HN; Nash R; Rovin BH
    Kidney Int; 2018 Oct; 94(4):788-794. PubMed ID: 30045812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study.
    Ichinose K; Kitamura M; Sato S; Eguchi M; Okamoto M; Endo Y; Tsuji S; Takatani A; Shimizu T; Umeda M; Fukui S; Sumiyoshi R; Koga T; Kawashiri S; Iwamoto N; Igawa T; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
    Lupus; 2019 Apr; 28(4):501-509. PubMed ID: 30755146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of Outcomes in Patients with Lupus Nephritis: Management Evolution in Chinese Patients from 1994 to 2010.
    Shao SJ; Hou JH; Xie GT; Sun W; Liang DD; Zeng CH; Zhu HX; Liu ZH
    J Rheumatol; 2019 Aug; 46(8):912-919. PubMed ID: 30824650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
    Smith E; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley D; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan A; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
    Lupus; 2019 Apr; 28(5):613-620. PubMed ID: 30871425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antineutrophil cytoplasmic antibody positivity at the time of renal biopsy is associated with disease activity of lupus nephritis.
    Zhang J; Lian R; Chen Y; Wan J
    Ren Fail; 2024 Dec; 46(2):2357743. PubMed ID: 38847502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
    Koo HS; Kim S; Chin HJ
    Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab as add-on therapy in patients with resistant lupus nephritis who have failed induction or maintenance therapy with other agents: A real-world experience from a single center in Mumbai.
    Yadav S; Balakrishnan C; Mangat G; Kothari J
    Lupus; 2024 Jan; 33(1):88-95. PubMed ID: 38048588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
    Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
    Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide.
    Ciruelo E; de la Cruz J; López I; Gómez-Reino JJ
    Arthritis Rheum; 1996 Dec; 39(12):2028-34. PubMed ID: 8961908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
    J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.